Amevive and Overdose - a phase IV clinical study of FDA data


Overdose is reported only by a few people who take Amevive.

The phase IV clinical study analyzes which people take Amevive and have Overdose. It is created by eHealthMe based on reports of 3,719 people who have side effects while taking Amevive from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2022

3,719 people reported to have side effects when taking Amevive.
Among them, 4 people (0.11%) have Overdose.

What is Amevive?

Amevive has active ingredients of alefacept. It is often used in psoriasis. eHealthMe is studying from 3,724 Amevive users for its effectiveness, alternative drugs and more.

What is Overdose?

Overdose is found to be associated with 2,841 drugs and 2,395 conditions by eHealthMe.

Number of Amevive and Overdose reports submitted per year:

Could Amevive cause Overdose?

Gender of people who have Overdose when taking Amevive *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Overdose when taking Amevive *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Amevive *:

  1. Methotrexate: 4 people, 100.00%
  2. Fentanyl: 4 people, 100.00%

Common side effects people have besides Overdose *:

  1. Confusional State: 4 people, 100.00%
  2. Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 4 people, 100.00%
  3. Dehydration (dryness resulting from the removal of water): 4 people, 100.00%
  4. Mouth Haemorrhage (bleeding from mouth): 4 people, 100.00%
  5. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 4 people, 100.00%
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 100.00%
  7. Pressure Ulcer: 3 people, 75.00%
  8. Escherichia Infection (bacterial infection by escherichia coli): 3 people, 75.00%
  9. Hyperbilirubinaemia (excess of bilirubin in the blood): 3 people, 75.00%
  10. Bacterial Sepsis: 3 people, 75.00%

* Approximation only. Some reports may have incomplete information.

Do you take Amevive and have Overdose?

Check whether Overdose is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Overdose and when was it recovered:

Expand to all the drugs that have ingredients of alefacept:

Alternative drugs to, pros and cons of Amevive:

Common Amevive side effects:

Browse all side effects of Amevive:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Overdose treatments and more:

COVID vaccines that are related to Overdose:

Common drugs associated with Overdose:

All the drugs that are associated with Overdose:

Common conditions associated with Overdose:

All the conditions that are associated with Overdose:

How the study uses the data?

The study uses data from the FDA. It is based on alefacept (the active ingredients of Amevive) and Amevive (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: